Technology Protection and Emerging-Technology Risk

The People Who Want Your Technology Rarely Break In

Some of the most consequential threats do not begin with a break-in. It is a foreign intelligence service, a competitor, or a strategic investor working patiently to acquire what you have built: through recruiting your researchers, investment and partnership offers, joint research, and travel. This is the outside interest coming for your most valuable work, and it comes through channels that look entirely legitimate. Fidelis helps founders, security leaders, counsel, and investors see how their research and IP are exposed to that interest, and document it in terms a board can act on.

01

Who Hires Fidelis

  • AI, defense-tech, biotech, and advanced-manufacturing companies protecting proprietary technology
  • Research organizations and universities managing sensitive programs and collaborations
  • GovCon and IP-intensive firms with contractual or national-interest sensitivity
  • Founders, boards, and investors who want an independent view of technology-protection risk

Engagements are scoped for companies without a large security organization. A focused review gives you and your board an independent view without committing to a year-long program.

02

How Sensitive Technology Actually Gets Targeted

Valuable technology is rarely lost through a dramatic breach. More often it leaves through legitimate-looking channels:

  • Recruiting and talent programs aimed at your key researchers
  • Investment, partnership, and acquisition interest that comes with strings attached
  • Academic and research collaboration that quietly widens access
  • Business travel to higher-risk jurisdictions
  • Vendors, contractors, and collaborators whose access grows faster than anyone tracks

Fidelis helps you see this exposure clearly and manage it in proportion, protecting your work without profiling your people.

03

Why Technology Exposure Is Underestimated

  • The value sits in IP, research, and a few key people as much as in systems
  • Exposure runs through vendors, partners, collaborators, travel, and hiring
  • Growth, funding, and new partnerships widen the surface faster than controls keep up
  • The loss is often invisible until it shows up in a competitor, a filing, or a market

04

What Fidelis Reviews

  • Sensitive-technology and IP exposure
  • Research and development risk
  • Vendor, partner, and contractor access
  • Personnel, travel, and facility risk
  • Information-handling and collaboration practices

05

What Fidelis Does

Fidelis reviews technology-protection risk from a people-, partner-, and information-centered perspective. In a typical engagement, Fidelis assesses where sensitive technology and IP are exposed, reviews research and development risk, evaluates vendor, partner, and contractor access, documents personnel, travel, facility, and information-handling risk, and delivers executive reporting for founders, security leaders, counsel, investors, or boards.

Fidelis provides independent review, documentation, and recommendations. It does not perform the technical security work it assesses, which keeps the reporting objective.

06

What Clients Receive

  • A review of your sensitive-technology and IP exposure
  • A research and development risk assessment
  • Documentation of vendor, partner, and access risk
  • Findings on personnel, travel, and information-handling risk
  • An executive summary and a decision-support briefing

Protecting valuable or sensitive technology?

Tell Fidelis what you need to protect and who you think wants it.